Search results for "Hypogeusia"

showing 2 items of 2 documents

An Online Observational Study of Patients With Olfactory and Gustory Alterations Secondary to SARS-CoV-2 Infection

2020

Introduction: Since the beginning of the Covid-19 epidemic produced by SARS2-Cov virus, olfactory alterations have been observed at a greater frequency than in other coronavirus epidemics. While olfactory alterations may be observed in patients with rhinovirus, influenza virus, or parainfluenza virus infection, they are typically explained by nasal obstruction with mucus or direct epithelial damage; in the case of SARS-CoV-2, olfactory alterations may present without nasal congestion with mucus. We performed a study of patients presenting olfactory/gustatory alterations in the context of SARS-CoV-2 infection in order to contribute to the understanding of this phenomenon. Material and Method…

AdultMalevirusesCentral nervous systemAnosmiacoronavirusPhysiologyNasal congestion03 medical and health sciencesOlfaction DisordersTaste Disorders0302 clinical medicineonline questionnaireHyposmiaSurveys and QuestionnairesmedicineHumans030212 general & internal medicineOriginal Researcholfactory alterationsneurologicalbusiness.industrySARS-CoV-2030503 health policy & servicesHypogeusialcsh:Public aspects of medicinePublic Health Environmental and Occupational Healthlcsh:RA1-1270Ageusiarespiratory systemDysosmiaDysgeusiamedicine.anatomical_structureCross-Sectional StudiesFemalePublic Healthmedicine.symptom0305 other medical sciencebusinessCovid-19anosmiaFrontiers in Public Health
researchProduct

COVID-19 and Alzheimer’s Disease

2021

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a neurotropic virus with a high neuroinvasive potential. Indeed, more than one-third of patients develop neurological symptoms, including confusion, headache, and hypogeusia/ageusia. However, long-term neurological consequences have received little interest compared to respiratory, cardiovascular, and renal manifestations. Several mechanisms have been proposed to explain the potential SARS-CoV-2 neurological injury that could lead to the development of neurodegenerative diseases, including Alzheimer’s Disease (AD). A mutualistic relationship between AD and COVID-19 seems to exist. On the one hand, COVID-19 patients seem to …

medicine.medical_specialtyNeurological injuryCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)neuroinflammation.DiseaseReviewneuroinflammationlcsh:RC321-57103 medical and health sciences0302 clinical medicineMedicineIntensive care medicinelcsh:Neurosciences. Biological psychiatry. NeuropsychiatryNeuroinflammation030304 developmental biologyNeurotropic virus0303 health sciencesneurodegenerative niseasebusiness.industrySARS-CoV-2General NeuroscienceHypogeusianervous systembiomarkersADAgeusiabiomarkermedicine.symptombusiness030217 neurology & neurosurgeryBrain Sciences
researchProduct